06/12/2017 - 2:36pm

The latest report on generics cost savings, compiled by the QuintilesIMS Institute on behalf of the Association for Accessible Medicines, highlights the key role generics play in healthcare cost savings. 

06/12/2017 - 12:23pm

The ophthalmic solution is a mast cell stabilizer indicated to treat ocular itching associated with allergic conjunctivitis.

06/09/2017 - 11:05am

According to the QuintilesIMS Institute’s 2017 Medicine Use and Spending report, Truvada had $3.1 billion in sales on an invoice price basis in 2016, ranking 17th among the top 20 medicines in the U.S. based on invoice spending.

06/06/2017 - 1:29pm
Teva’s authorized generic is available in 5-, 10-, 15- and 20-mcg/hour strengths. 
06/02/2017 - 12:27pm

The National Association of Chain Drug Stores and the American Pharmacists Association shared their concerns with the Trump Administration about the potential impact of drug importation on patient safety and the delivery of value-based care. 

06/02/2017 - 10:35am

Mylan is introducing a generic of Novartis' Reclast injection, which treats Paget's disease of the bone, and Teva's Azilect, a Parkinson’s disease treatment. 

06/01/2017 - 1:08pm

The acquisition gives Sawai a foothold in the U.S. generics market, and the company will retain Rusty Field as the president of the company, adding the role of CEO to his duties.

05/31/2017 - 1:44pm
Apotex, Aurobindo, Teva and Glenmark all earned approval from the regulatory to market the drug in multiple strengths.
05/31/2017 - 12:21pm

Mallinckrodt, in an effort to focus more on branded products, is looking for a buyer for its generics division who could pay as much as $2 billion for the business, according to a Reuters report. Reuters noted that the company’s generics sales have dropped roughly 18% between 2015 and 2016 — a period during which its branded specialty sales grew by some 40%, partially through acquisitions. (Reuters)